Mesenchymal Cell News 11.24 June 25, 2019 | |
| |
TOP STORYInvestigators found that meflin had an inhibitory role in myofibroblasts differentiation of cultured MSCs. Meflin expression was downregulated by stimulation with transforming growth factor-β, substrate stiffness, hypoxia, and aging. Histological analysis revealed that meflin-positive fibroblastic cells and their lineage cells proliferated in the hearts after acute myocardial infarction and pressure-overload heart failure mouse models. [Circ Res] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)IN VITROResearchers examined the regulation of adipogenesis in human subcutaneous adipose tissue (SAT) precursor cells and found ZNF521 to be a critical regulator of early adipogenic commitment and precursor cells leaving the cell cycle. However, neither altered upstream signaling nor lack of SAT progenitor cells could explain the reduced adipogenesis in hypertrophic obesity. [Nat Commun] Full Article By creating an experimental and computational analysis platform, the authors reconstructed dynamic secretory signatures of cells based on a very limited number of time points. By using this approach, they demonstrated that the secretory signatures of CD133-positive bone-marrow derived stromal cells were uniquely defined by distinct biological contexts, including signals from injured cardiac cells undergoing oxidative stress, characteristic of cardiac infarction. [Proc Natl Acad Sci USA] Abstract Investigators profiled the expression changes of lncRNAs and found that antidifferentiation noncoding RNA (ANCR) was downregulated during the differentiation of both human adipose-derived (hA)MSCs and embryonic stem cells (ESCs) to definitive endoderm (DE) cells. ANCR knockdown resulted in the elevated expression of DE markers in hAMSCs, but not in ESCs. [Cell Death Dis] Full Article Scientists examined the protective effects LIPUS on the maintenance of osteogenic potency. Primary osteoblastic cells were serially passaged between 2 and 12 times with daily LIPUS treatment. [Cell Signal] Abstract Evaluation of Neurosecretome from Mesenchymal Stem Cells Encapsulated in Silk Fibroin Hydrogels Although the survival of mesenchymal stem cells was not affected inside hydrogels, the silk biomaterial format caused adhesion and proliferation deficits and impaired secretion of several angiogenic, chemoattractant and neurogenic factors while concurrently potentiating the anti-inflammatory capacity of this cell population through a massive release of TGF-Beta-1. [Sci Rep] Full Article The authors performed biotinylation combined with glycocapture and high throughput shotgun proteomics to define the surface proteome of human bone marrow MSCs and human chondrogenic progenitor cells (CPCs). They prepared cell surface protein-enriched fractions from MSCs and CPCs, and then a proteomic approach was used to compare and evaluate protein changes between undifferentiated MSCs and CPCs. [Sci Rep] Full Article Biocompatibility of grafts was assessed by testing the effect of extraction medium on MSC viability and comparing them to commercially available allografts and xenografts. Additionally, grafts’ performance in terms of MSC functionality was assessed by reseeding with MSCs pre-differentiated in osteogenic medium and determining cell adhesion, proliferation, as well as alkaline phosphatase activity and the degree of mineralization. [PLoS One] Full Article Investigators compared the ability and efficiency of differentiation of MSCs isolated from bone marrow (BM-MSCs) and adipose tissue (ADSC) into cardiomyocyte-like cells to aid translational research. To fulfill this aim, freshly isolated BM-MSCs and ADSCs were differentiated into cardiomyocytes using 5-Azacytidine and TGF-β1. [Mol Cell Biochem] Abstract IN VIVOA double-blind dose-finding study for local bone marrow (bm)MSC-therapy in 21 patients with refractory perianal fistulising Crohn’s disease was performed at the Leiden University Medical Center in 2012-2014. All patients treated with bmMSCs were invited for a four-year evaluation. [J Crohns Colitis] Abstract The authors showed the in vitro and in vivo effects of Ginkgolide B (GB) on osteoblast differentiation and bone formation. They found that GB promoted osteoblast differentiation of bone MSCs and MC3T3-E1 cells in vitro in a Wnt/β-catenin-dependent manner. [J Cell Mol Med] Full Article Researchers tested the hypothesis that rat adipose-derived MSCs produce a amount of soluble tumor necrosis factor receptor 1, which ameliorated liver injury and inflammation and increased the survival rate of septic rat model. [Exp Cell Res] Abstract Subscribe to one of our other 19 science newsletters such as ESC & iPSC News & Cell Therapy News. | |
| |
REVIEWSMesenchymal Stem Cells Empowering Tendon Regenerative Therapies Scientists provide an overview of the main challenges in the field of cell-based regenerative therapies, discussing the role of MSCs in boosting tendon regeneration, particularly through their capacity to enhance the tenogenic properties of tendon resident cells. [Int J Mol Sci] Full Article Prospects for the Application of Mesenchymal Stem Cells in Alzheimer’s Disease Treatment Therapies based on MSCs have provided hopeful results in experimental models regarding several disorders. MSCs enhance the levels of functional recoveries in pathologic experimental models of central nervous system and are being investigated in clinical trials in neurological disorders. [Life Sci] Abstract | Graphical Abstract Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field. | |
| |
INDUSTRY NEWSKrystal Biotech, Inc. announced positive results from its Phase II placebo-controlled clinical trial of KB103 study and an update on results from its Phase I study. [Krystal Biotech, Inc.] Press Release Scientists at the New York Genome Center and the Icahn School of Medicine at Mount Sinai have been awarded a $1.5 million collaborative grant over three years from the Chan Zuckerberg Initiative to support the development of a toolkit for integrated multimodal cell profiling. [New York Genome Center] Press Release | |
| |
POLICY NEWSIranian Biologists Face US Trial for Trying to Take Proteins Out of the Country Three Iranian biologists are facing trial in a US court over charges that they violated trade sanctions by attempting to export chemicals known as growth factors, which are commonly used in medical research. The scientists have asked a federal district court judge in Atlanta, Georgia, to dismiss the criminal charges against them. [Nature News] Editorial UK’s Leading Mouse Genetics Center Faces Closure Britain’s leading center for mouse genetics is facing closure in a move that critics say will undermine crucial research on serious diseases and threaten the standing of UK science. The Medical Research Council has told staff at its Harwell Institute in Oxfordshire that an internal strategy board recommended the closure of all academic work at the site, threatening research on diabetes, neurodegenerative disease, child deafness and other conditions. [The Guardian] Editorial House Panel Clarifies How Universities Would Report Sexual Harassment Cases to US Funders New rules from the National Science Foundation (NSF) on reporting sexual harassment by someone with an NSF grant raise questions about due process, university administrators say. A key congressional panel took those concerns to heart by modifying language in a bill that would require the administration to write guidelines applying to half a dozen major federal research agencies. [ScienceInsider] Editorial
| |
EVENTSNEW The New York Stem Cell Conference Foundation Conference Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Assistant Director – Cell & Gene Therapy (MD Anderson Cancer Center) NEW Postdoctoral Fellow – Immunology & Respiratory Disease Research with MSCs (Boehringer Ingelheim) NEW Postdoctoral Researcher – Lung Repair (University of California San Francisco Medical Centre) NEW Development Scientist – Cell Therapy (GE) Postdoctoral Researchers – Cardiometabolic Diseases (Columbia University Medical Center) Postdoctoral Fellow – MSCs in Skeletal Development (University of Pennsylvania) Assistant Professor – Musculoseketal Biology (Keck School of Medicine of USC) Assistant Professor – Sarcoma or Skeletal Related Malignancies (University of California at Davis) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|